With no end in sight to the COVID-19 pandemic, the US Food and Drug Administration is planning for an extended run of virtual advisory committee meetings.
The Center for Drug Evaluation and Research has created an internal team dedicated to working on virtual AdComms and sharing best practices among review divisions
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?